FDA Approval of BELBUCA™ (CIII) (Buprenorphine HCl) Buccal Film for Chronic Pain Triggers Milestone Payment of $50 Million to BioDelivery Sciences from Partner Endo Pharmaceuticals

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. IBM
4. SPCX
5. ACN
6. NVDA
7. PRIM
8. META
9. SPY
10. DPZ

Go back to FDA Approval of BELBUCA™ (CIII) (Buprenorphine HCl) Buccal Film for Chronic Pain Triggers Milestone Payment of $50 Million to BioDelivery Sciences from Partner Endo Pharmaceuticals
BioDelivery Sciences Internati (NASDAQ: BDSI) Delayed: 5.59 --0 (-0%)
Previous Close $5.59    52 Week High $6.40 
Open $111.97    52 Week Low $1.75 
Day High $5.59    P/E N/A 
Day Low $5.59    EPS $-1.25 
Volume 4,375,719       

ENDO INTERNAT (NASDAQ: ENDP) Delayed: 0.29 --0 (-0%)
Previous Close $0.29    52 Week High $63.71 
Open $0.02    52 Week Low $12.56 
Day High $0.29    P/E N/A 
Day Low $0.29    EPS $0.00 
Volume 24,300       

REED ELSEVIER NV (NYSE: ENL) Delayed: 46.85 --0 (-0%)
Previous Close $46.85    52 Week High $51.81 
Open $14.07    52 Week Low $15.63 
Day High $46.85    P/E N/A 
Day Low $46.85    EPS $0.00 
Volume 79,573